LNLuciana Bertholim Nasciben

Luciana Bertholim Nasciben

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Luciana Bertholim Nasciben has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Exploring potential mechanisms of an African protective locus for Alzheimer's disease in APOEε4 carriers

    by Luciana Bertholim‐Nasciben, Karen Nuytemans, Derek Van Booven, Farid Rajabli, Sofia Moura, Aura M. Ramirez, Griffin S. Parker, Derek M. Dykxhoorn, Liyong Wang, William K. Scott, et al.

    INTRODUCTION: We recently described that the African‐specific A allele of rs10423769, which lies in an area of segmental duplications, reduces Alzheimer's disease (AD) risk by ∼ 75% in apolipoprotein E ( APOE) ε4 homozygotes. METHODS: Short and long‐read sequencing were used to identify the haplotype harboring rs10423769_A and examine DNA methylation and structural variation (SV). RESULTS: A unique 21 kb haplotype is shared amongst all rs10423769_A carriers (r 2 > 0.95) and is present in all African ancestry tested. We identified methylation differences between the non‐protective and rs10423769_A haplotypes. An expanded variable number tandem repeat (VNTR) containing multiple MEF2‐family transcription factor binding motifs in LD with the protective haplotype. Further, rs10423769 is an eQTL for ZNF222 . DISCUSSION: The protective haplotype is unique, with haplotype changes in DNA methylation and SV that could contribute to the protective mechanism of rs10423769_A. The study generates hypothesis for future studies on this important protective mechanism for APOEε4 carriers. Highlights: We investigated an African‐specific haplotype harboring a protective locus for APOEε4 carriers that significantly reduces the risk for Alzheimer Disease. The protective locus lies in an area of segmental duplications 2MB from APOE . We found that the protective haplotype is unique within the segmental duplications. The haplotype is found in all African ancestry tested but not in other ancestries. Long read whole genome sequencing identified an expanded VNTR associated with the protective haplotype containing multiple MEF2 transcription factor binding motifs. Differences in DNA methylation were found between the protective and the reference haplotype.


  • Open Access

    Comparing Alzheimer's genes in African, European, and Amerindian induced pluripotent stem cell–derived microglia

    by Sofia Moura, Luciana Bertholim Nasciben, Aura M. Ramirez, Lauren Coombs, Joe Rivero, Derek J. Van Booven, Brooke A. DeRosa, Kara L. Hamilton‐Nelson, Patrice L. Whitehead, Larry D. Adams, et al.

    INTRODUCTION: Genome‐wide association studies (GWAS) studies in Alzheimer's disease (AD) demonstrate ancestry‐specific loci. Previous studies in the regulatory architecture have only been conducted in Europeans (EUs), thus studies in additional ancestries are needed. Given the prevalence of AD genes expressed in microglia, we initiated our studies in induced pluripotent stem cell (iPSC) ‐derived microglia. METHODS: We created iPSC‐derived microglia from 13 individuals of either high Amerindian (AI), African (AF), or EU global ancestry, including both AD and controls. RNA‐seq, ATAC‐seq, and pathway analyses were compared between ancestries in both AD and non‐AD genes. RESULTS: Twelve AD genes were differentially expressed genes (DEGs) and/or accessible between ancestries, including ABI3 , CTSB , and MS4A6A . A total of 5% of all genes had differential ancestral expression, but differences in accessibility were less than 1%. The DEGs were enriched in known AD pathways. DISCUSSION: This resource will be valuable in evaluating AD in admixed populations and other neurological disorders and understanding the AD risk differences between populations. Highlights: First comparison of the genomics of AI, AF, and EU microglia. Report differences in expression and accessibility of AD genes between ancestries. Ancestral expression differences are greater than differences in accessibility. Good transcriptome correlation was seen between brain and iPSC‐derived microglia. Differentially expressed AD genes were in known AD pathways.


  • Open Access

    Gene expression and chromatin accessibility comparison in iPSC-derived microglia in African, European, and Amerindian genomes in Alzheimer’s patients and controls

    by Sofia Moura, Luciana Bertholim Nasciben, Aura M. Ramirez, Lauren Coombs, Joe Rivero, Derek J. Van Booven, Brooke A. DeRosa, Kara L. Hamilton-Nelson, Patrice L. Whitehead, Larry D. Adams, et al.

    Alzheimer’s disease (AD) risk differs between population groups, with African Americans and Hispanics being the most affected groups compared to non-Hispanic Whites. Genetic factors contribute significant risk to AD, but the genetic regulatory architectures (GRA) have primarily been studied in Europeans. Many AD genes are expressed in microglia; thus, we explored the impact of genetic ancestry (Amerindian (AI), African (AF), and European (EU)) on the GRA in iPSC-derived microglia from 13 individuals (∼4 each with high global ancestry, AD and controls) through ATAC-seq and RNA-seq analyses. We identified several differentially accessible and expressed genes (2 and 10 AD-related, respectively) between ancestry groups. We also found a high correlation between the transcriptomes of iPSC-derived and brain microglia, supporting their use in human studies. This study provides valuable insights into genetically diverse microglia beyond the analysis of AD.